250 related articles for article (PubMed ID: 24141140)
21. Defective acid sphingomyelinase pathway with Pseudomonas aeruginosa infection in cystic fibrosis.
Yu H; Zeidan YH; Wu BX; Jenkins RW; Flotte TR; Hannun YA; Virella-Lowell I
Am J Respir Cell Mol Biol; 2009 Sep; 41(3):367-75. PubMed ID: 19168701
[TBL] [Abstract][Full Text] [Related]
22. Proresolving Action of Docosahexaenoic Acid Monoglyceride in Lung Inflammatory Models Related to Cystic Fibrosis.
Morin C; Cantin AM; Rousseau É; Sirois M; Sirois C; Rizcallah E; Fortin S
Am J Respir Cell Mol Biol; 2015 Oct; 53(4):574-83. PubMed ID: 25781052
[TBL] [Abstract][Full Text] [Related]
23. Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis.
Teichgräber V; Ulrich M; Endlich N; Riethmüller J; Wilker B; De Oliveira-Munding CC; van Heeckeren AM; Barr ML; von Kürthy G; Schmid KW; Weller M; Tümmler B; Lang F; Grassme H; Döring G; Gulbins E
Nat Med; 2008 Apr; 14(4):382-91. PubMed ID: 18376404
[TBL] [Abstract][Full Text] [Related]
24. IL-17 primes airway epithelial cells lacking functional Cystic Fibrosis Transmembrane conductance Regulator (CFTR) to increase NOD1 responses.
Roussel L; Rousseau S
Biochem Biophys Res Commun; 2010 Jan; 391(1):505-9. PubMed ID: 19931506
[TBL] [Abstract][Full Text] [Related]
25. Effects of sphingolipid synthesis inhibition on cholesterol gallstone formation in C57BL/6J mice.
Lee BJ; Kim JS; Kim BK; Jung SJ; Joo MK; Hong SG; Kim JS; Kim JH; Yeon JE; Park JJ; Byun KS; Bak YT; Yoo HS; Oh S
J Gastroenterol Hepatol; 2010 Jun; 25(6):1105-10. PubMed ID: 20594226
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of Pseudomonas aeruginosa secreted virulence factors reduces lung inflammation in CF mice.
Sandri A; Ortombina A; Boschi F; Cremonini E; Boaretti M; Sorio C; Melotti P; Bergamini G; Lleo M
Virulence; 2018; 9(1):1008-1018. PubMed ID: 29938577
[TBL] [Abstract][Full Text] [Related]
27. Neutrophil elastase increases airway ceramide levels via upregulation of serine palmitoyltransferase.
Karandashova S; Kummarapurugu AB; Zheng S; Chalfant CE; Voynow JA
Am J Physiol Lung Cell Mol Physiol; 2018 Jan; 314(1):L206-L214. PubMed ID: 29025713
[TBL] [Abstract][Full Text] [Related]
28. Cystic fibrosis fatty acid imbalance is linked to ceramide deficiency and corrected by fenretinide.
Guilbault C; Wojewodka G; Saeed Z; Hajduch M; Matouk E; De Sanctis JB; Radzioch D
Am J Respir Cell Mol Biol; 2009 Jul; 41(1):100-6. PubMed ID: 19059886
[TBL] [Abstract][Full Text] [Related]
29. MPB-07 reduces the inflammatory response to Pseudomonas aeruginosa in cystic fibrosis bronchial cells.
Dechecchi MC; Nicolis E; Bezzerri V; Vella A; Colombatti M; Assael BM; Mettey Y; Borgatti M; Mancini I; Gambari R; Becq F; Cabrini G
Am J Respir Cell Mol Biol; 2007 May; 36(5):615-24. PubMed ID: 17197571
[TBL] [Abstract][Full Text] [Related]
30. Effects of cystic fibrosis transmembrane conductance regulator and DeltaF508CFTR on inflammatory response, ER stress, and Ca2+ of airway epithelia.
Hybiske K; Fu Z; Schwarzer C; Tseng J; Do J; Huang N; Machen TE
Am J Physiol Lung Cell Mol Physiol; 2007 Nov; 293(5):L1250-60. PubMed ID: 17827250
[TBL] [Abstract][Full Text] [Related]
31. Inflammation in cystic fibrosis airways: relationship to increased bacterial adherence.
Scheid P; Kempster L; Griesenbach U; Davies JC; Dewar A; Weber PP; Colledge WH; Evans MJ; Geddes DM; Alton EW
Eur Respir J; 2001 Jan; 17(1):27-35. PubMed ID: 11307750
[TBL] [Abstract][Full Text] [Related]
32. Lipidomics Analysis Reveals a Protective Effect of Myriocin on Cerebral Ischemia/Reperfusion Model Rats.
Wang T; Zhang J; Yang M; Guo J; Li D; Li Y
J Mol Neurosci; 2022 Sep; 72(9):1846-1858. PubMed ID: 35776315
[TBL] [Abstract][Full Text] [Related]
33. Evidence for the Involvement of Lipid Rafts and Plasma Membrane Sphingolipid Hydrolases in
Schiumarini D; Loberto N; Mancini G; Bassi R; Giussani P; Chiricozzi E; Samarani M; Munari S; Tamanini A; Cabrini G; Lippi G; Dechecchi MC; Sonnino S; Aureli M
Mediators Inflamm; 2017; 2017():1730245. PubMed ID: 29333001
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption.
Ussher JR; Koves TR; Cadete VJ; Zhang L; Jaswal JS; Swyrd SJ; Lopaschuk DG; Proctor SD; Keung W; Muoio DM; Lopaschuk GD
Diabetes; 2010 Oct; 59(10):2453-64. PubMed ID: 20522596
[TBL] [Abstract][Full Text] [Related]
35. Innate lung defenses and compromised Pseudomonas aeruginosa clearance in the malnourished mouse model of respiratory infections in cystic fibrosis.
Yu H; Nasr SZ; Deretic V
Infect Immun; 2000 Apr; 68(4):2142-7. PubMed ID: 10722612
[TBL] [Abstract][Full Text] [Related]
36. Anoctamin 1 dysregulation alters bronchial epithelial repair in cystic fibrosis.
Ruffin M; Voland M; Marie S; Bonora M; Blanchard E; Blouquit-Laye S; Naline E; Puyo P; Le Rouzic P; Guillot L; Corvol H; Clement A; Tabary O
Biochim Biophys Acta; 2013 Dec; 1832(12):2340-51. PubMed ID: 24080196
[TBL] [Abstract][Full Text] [Related]
37. Effect of myriocin on plasma sphingolipid metabolism and atherosclerosis in apoE-deficient mice.
Hojjati MR; Li Z; Zhou H; Tang S; Huan C; Ooi E; Lu S; Jiang XC
J Biol Chem; 2005 Mar; 280(11):10284-9. PubMed ID: 15590644
[TBL] [Abstract][Full Text] [Related]
38. Ceramide in cystic fibrosis.
Grassmé H; Riethmüller J; Gulbins E
Handb Exp Pharmacol; 2013; (216):265-74. PubMed ID: 23563661
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of ceramide de novo synthesis reduces liver lipid accumulation in rats with nonalcoholic fatty liver disease.
Kurek K; Piotrowska DM; Wiesiołek-Kurek P; Łukaszuk B; Chabowski A; Górski J; Zendzian-Piotrowska M
Liver Int; 2014 Aug; 34(7):1074-83. PubMed ID: 24106929
[TBL] [Abstract][Full Text] [Related]
40. Glucosylceramide Critically Contributes to the Host Defense of Cystic Fibrosis Lungs.
Kovacic B; Sehl C; Wilker B; Kamler M; Gulbins E; Becker KA
Cell Physiol Biochem; 2017; 41(3):1208-1218. PubMed ID: 28427052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
